|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:16673309 |
RGD:2325824 |
NCBI chrNW_004955444:17,116,060...17,320,966
Ensembl chrNW_004955444:17,121,559...17,318,295
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17341899 |
|
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:17419223 |
RGD:2317786 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Il6 |
interleukin 6 |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:17617204 |
RGD:2317166 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15892172 |
RGD:2317585 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
severity |
ISO |
protein:decreased expression:carcinoma of extrahepatic bile duct (human) |
RGD |
PMID:11986189 |
RGD:2317662 |
NCBI chrNW_004955477:7,103,035...7,375,073
Ensembl chrNW_004955477:7,102,977...7,376,530
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:9869516 |
RGD:2317706 |
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
protein:increased expression:serum,bile |
RGD |
PMID:1657243 |
RGD:2325134 |
NCBI chrNW_004955563:432,160...581,330
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:16857800 |
RGD:2324929 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
disease_progression |
ISO |
|
RGD |
PMID:8501910 PMID:9851639 |
RGD:2326076 RGD:2326077 |
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:15471559 |
RGD:2324957 |
NCBI chrNW_004955452:4,580,444...4,606,820
Ensembl chrNW_004955452:4,579,331...4,636,884
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:25704541 |
RGD:11521169 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
|
G |
Apob |
apolipoprotein B |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004955469:3,437,422...3,478,408
Ensembl chrNW_004955469:3,436,450...3,478,424
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:SNP:intron:rs440446 (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
|
|
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955421:3,890,291...3,936,892
Ensembl chrNW_004955421:3,890,306...3,936,526
|
|
G |
Msh2 |
mutS homolog 2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:33357406 |
|
NCBI chrNW_004955441:14,188,315...14,247,608
Ensembl chrNW_004955441:14,187,805...14,247,698
|
|
G |
Palb2 |
partner and localizer of BRCA2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823 |
|
NCBI chrNW_004955493:2,149,053...2,175,482
Ensembl chrNW_004955493:2,147,862...2,175,781
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
|
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004955559:712,375...730,551
Ensembl chrNW_004955559:712,321...725,661
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955495:6,678,195...6,699,408
Ensembl chrNW_004955495:6,678,195...6,699,058
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chrNW_004955416:28,640,807...28,869,717
Ensembl chrNW_004955416:28,654,905...28,870,555
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:10776430 PMID:17545000 PMID:20431764 |
RGD:2325679 RGD:2325680 RGD:2325682 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chrNW_004955546:2,495,226...2,550,909
Ensembl chrNW_004955546:2,494,819...2,550,909
|
|
G |
Anxa2 |
annexin A2 |
disease_progression |
ISO |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:loss of heterozygosity DNA:hypermethylation:promoter |
RGD |
PMID:10212000 PMID:15467712 |
RGD:2317198 RGD:2317205 |
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chrNW_004955444:17,116,060...17,320,966
Ensembl chrNW_004955444:17,121,559...17,318,295
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004955547:2,436,974...2,446,849
Ensembl chrNW_004955547:2,436,895...2,446,849
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Birc6 |
baculoviral IAP repeat containing 6 |
ameliorates |
ISO |
mRNA:increased expression:bile duct (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004955441:740,299...923,920
Ensembl chrNW_004955441:739,567...922,959
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955453:15,181,027...15,196,224
Ensembl chrNW_004955453:15,194,205...15,195,272
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955496:325,954...401,430
Ensembl chrNW_004955496:328,075...401,569
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Epo |
erythropoietin |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004955495:2,293,587...2,299,302
Ensembl chrNW_004955495:2,293,540...2,298,715
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chrNW_004955451:14,442,816...14,456,009
Ensembl chrNW_004955451:14,442,816...14,459,379
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression no_association |
ISO |
DNA:SNP: :g.148505302C>T (rs887569) (human) DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) |
RGD |
PMID:24179546 |
RGD:126779604 |
NCBI chrNW_004955491:4,215,353...4,292,229
Ensembl chrNW_004955491:4,215,298...4,292,235
|
|
G |
Faslg |
Fas ligand |
|
ISO |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
protein:increased expression:bile |
RGD |
PMID:11478488 |
RGD:2317765 |
NCBI chrNW_004955428:17,840,554...17,894,779
Ensembl chrNW_004955428:17,840,628...17,894,773
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955551:2,321,190...2,427,000
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
human cell line in a mouse model DNA:hypermethylation:promoter |
RGD |
PMID:12805482 PMID:15467712 |
RGD:14401711 RGD:2317198 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Hdac6 |
histone deacetylase 6 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chrNW_004955543:348,314...378,391
Ensembl chrNW_004955543:348,019...378,071
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317909 RGD:2317925 |
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955406:42,376,102...42,384,902
Ensembl chrNW_004955406:42,376,104...42,384,902
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955470:7,518,565...7,562,219
Ensembl chrNW_004955470:7,518,663...7,559,470
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Ins |
insulin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chrNW_004955479:2,062,607...2,545,576
Ensembl chrNW_004955479:2,062,608...2,543,125
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955447:16,149,014...16,226,151
Ensembl chrNW_004955447:16,148,605...16,226,734
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chrNW_004955547:2,584,425...2,598,770
Ensembl chrNW_004955547:2,533,377...2,598,833
|
|
G |
LOC102013768 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
|
ISO |
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human) |
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chrNW_004955445:4,874,583...4,891,723
Ensembl chrNW_004955445:4,873,942...4,891,780
|
|
G |
LOC102023786 |
cytochrome c, somatic |
|
ISO |
|
RGD |
PMID:19788692 |
RGD:2317615 |
NCBI chrNW_004955410:27,086,405...27,089,255
Ensembl chrNW_004955410:27,086,405...27,089,255
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chrNW_004955458:15,264,028...15,287,290
Ensembl chrNW_004955458:15,263,739...15,286,808
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat) |
RGD |
PMID:14656942 PMID:16818635 |
RGD:2317578 RGD:2317601 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mfsd4a |
major facilitator superfamily domain containing 4A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955406:41,286,679...41,315,666
Ensembl chrNW_004955406:41,286,679...41,322,158
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chrNW_004955477:7,103,035...7,375,073
Ensembl chrNW_004955477:7,102,977...7,376,530
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667 RGD:2325769 |
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:bile duct mRNA:increased expression:bile duct |
RGD |
PMID:15213623 PMID:16463672 |
RGD:2324667 RGD:2325856 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
mRNA:increased expression:bile duct protein:increased expression:serum protein:increased expression:bile duct: protein:increased secretion:bile |
RGD |
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217 |
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chrNW_004955563:432,160...581,330
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955476:11,108,826...11,135,697
Ensembl chrNW_004955476:11,108,826...11,135,697
|
|
G |
Muc3a |
mucin 3A, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955573:45,920...60,091
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:14752841 PMID:19082442 |
RGD:2303602 RGD:2324944 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
ISO |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:11680592 PMID:14508831 |
RGD:2324948 RGD:2324990 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955476:11,021,665...11,049,239
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
ISO |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chrNW_004955476:11,165,423...11,184,674
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16094703 PMID:16818635 |
RGD:2325280 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chrNW_004955513:4,225,939...4,264,875
Ensembl chrNW_004955513:4,225,956...4,263,259
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
disease_progression |
ISO |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11260864 PMID:11866974 |
RGD:2317134 RGD:2317136 |
NCBI chrNW_004955561:1,277,362...1,282,949
Ensembl chrNW_004955561:1,277,365...1,282,793
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004955455:4,928,153...5,110,178
Ensembl chrNW_004955455:4,928,207...5,110,999
|
|
G |
Osbpl7 |
oxysterol binding protein like 7 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004955451:13,289,938...13,301,243
Ensembl chrNW_004955451:13,291,577...13,300,322
|
|
G |
Panx2 |
pannexin 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955413:33,220,145...33,224,241
Ensembl chrNW_004955413:33,220,140...33,224,344
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chrNW_004955405:18,434,711...18,540,710
Ensembl chrNW_004955405:18,434,711...18,540,710
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Peg3 |
paternally expressed 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955567:85,913...96,236
|
|
G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34845814 |
|
NCBI chrNW_004955455:4,794,189...4,808,235
Ensembl chrNW_004955455:4,792,182...4,808,258
|
|
G |
Pir |
pirin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955519:2,698,207...2,813,201
Ensembl chrNW_004955519:2,698,172...2,813,206
|
|
G |
Ppia |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human cell line and construct in a mouse model |
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chrNW_004955456:7,381,923...7,383,203
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955496:6,934,542...7,059,745
Ensembl chrNW_004955496:6,908,224...7,059,816
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chrNW_004955444:11,154,318...11,414,680
Ensembl chrNW_004955444:11,154,318...11,414,075
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955415:32,794,172...32,807,944
Ensembl chrNW_004955415:32,793,718...32,812,930
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955423:9,630,308...9,747,820
Ensembl chrNW_004955423:9,629,378...9,747,820
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955422:13,305,422...13,327,188
Ensembl chrNW_004955422:13,305,549...13,326,964
|
|
G |
Prss56 |
serine protease 56 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955453:3,440,871...3,446,090
Ensembl chrNW_004955453:3,441,109...3,446,090
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23376645 PMID:27022031 |
RGD:12802341 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
|
|
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Rassf8 |
Ras association domain family member 8 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955413:21,029,725...21,052,837
Ensembl chrNW_004955413:20,929,095...21,053,087
|
|
G |
Rnf39 |
ring finger protein 39 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955583:201,638...206,754
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human) |
CTD RGD |
PMID:22561520 |
RGD:151361227 |
NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955407:14,301,689...15,549,561
Ensembl chrNW_004955407:14,305,498...14,842,790
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chrNW_004955452:4,580,444...4,606,820
Ensembl chrNW_004955452:4,579,331...4,636,884
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955447:1,599,986...1,900,791
Ensembl chrNW_004955447:1,599,929...1,900,791
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chrNW_004955524:3,372,539...3,380,758
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression treatment |
ISO |
|
RGD |
PMID:24131658 PMID:25475870 PMID:28347255 |
RGD:151361214 RGD:151361287 RGD:151361294 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
severity |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004955506:4,222,455...4,225,563
Ensembl chrNW_004955506:4,222,455...4,225,563
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004955454:13,689,403...13,690,019
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955420:10,671,888...10,674,080
Ensembl chrNW_004955420:10,671,978...10,672,934
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
disease_progression |
ISO |
protein:increased expression:pancreas |
RGD |
PMID:12632524 PMID:16083599 |
RGD:1299231 RGD:2325020 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tgfbr2 |
transforming growth factor beta receptor 2 |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chrNW_004955430:21,919,338...21,999,688
Ensembl chrNW_004955430:21,932,553...22,001,837
|
|
G |
Thbs1 |
thrombospondin 1 |
disease_progression |
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:11927969 PMID:12213730 PMID:16465407 |
RGD:2325024 RGD:2325026 RGD:2325027 |
NCBI chrNW_004955416:6,490,034...6,506,419
Ensembl chrNW_004955416:6,489,451...6,506,419
|
|
G |
Tnc |
tenascin C |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004955419:12,569,620...12,662,897
Ensembl chrNW_004955419:12,569,547...12,662,958
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
severity |
ISO |
protein:increased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004955436:21,566,591...21,581,551
Ensembl chrNW_004955436:21,566,423...21,578,469
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chrNW_004955402:18,921,235...18,927,976
Ensembl chrNW_004955402:18,921,274...18,928,108
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955437:9,527,445...9,541,908
|
|
G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
ameliorates |
ISO |
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chrNW_004955409:8,539,617...8,587,537
|
|
G |
Wnt9a |
Wnt family member 9A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955581:422,028...438,321
Ensembl chrNW_004955581:421,451...438,380
|
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18076041 |
RGD:2325763 |
NCBI chrNW_004955469:3,437,422...3,478,408
Ensembl chrNW_004955469:3,436,450...3,478,424
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
|
ISO |
mRNA, protein:increased expression: : |
RGD |
PMID:15136764 |
RGD:2317789 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Mtap |
methylthioadenosine phosphorylase |
|
ISO |
DNA, protein:deletion, decreased expression:common bile duct: |
RGD |
PMID:15662124 |
RGD:2317954 |
NCBI chrNW_004955472:12,391,399...12,439,221
Ensembl chrNW_004955472:12,390,032...12,439,206
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:8766528 |
RGD:2324856 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISO |
protein:increased expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Tymp |
thymidine phosphorylase |
disease_progression |
ISO |
|
RGD |
PMID:10760693 |
RGD:2325158 |
NCBI chrNW_004955413:33,505,424...33,509,095
Ensembl chrNW_004955413:33,505,446...33,508,748
|
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
protein:increased expression:mucosa (human) |
RGD |
PMID:21537609 |
RGD:153350126 |
NCBI chrNW_004955460:13,270,159...13,295,562
Ensembl chrNW_004955460:13,270,159...13,311,351
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004955559:712,375...730,551
Ensembl chrNW_004955559:712,321...725,661
|
|
G |
Xpo1 |
exportin 1 |
disease_progression |
ISO |
protein:increased expression:extrahepatic bile duct (human) |
RGD |
PMID:27279267 |
RGD:151665800 |
NCBI chrNW_004955424:22,370,006...22,420,568
Ensembl chrNW_004955424:22,370,006...22,420,568
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma |
ClinVar |
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
|
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression exacerbates |
ISO |
mRNA,protein:decreased expression:intrahepatic bile duct (human) |
RGD |
PMID:27433094 PMID:30849962 PMID:31665232 |
RGD:126775257 RGD:126781775 RGD:14974231 |
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:27864835 |
RGD:150340628 |
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Becn1 |
beclin 1 |
disease_progression |
ISO |
|
RGD |
PMID:30849962 |
RGD:14974231 |
NCBI chrNW_004955451:16,616,595...16,625,731
Ensembl chrNW_004955451:16,616,595...16,625,730
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Faslg |
Fas ligand |
severity |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
DNA:hypomethylation:liver |
RGD |
PMID:24291052 |
RGD:38599002 |
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955538:1,469,544...1,475,010
Ensembl chrNW_004955538:1,469,544...1,475,019
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955437:9,872,649...9,878,459
Ensembl chrNW_004955437:9,873,908...9,878,459
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
no_association |
ISO |
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human) |
RGD |
PMID:26245674 |
RGD:14974229 |
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
disease_progression |
ISO |
mRNA:decreased expression:liver (mouse) DNA:mutations: : |
RGD |
PMID:22824796 PMID:32463951 |
RGD:149735894 RGD:14985256 |
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Kdm5c |
lysine demethylase 5C |
exacerbates |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:32714863 |
RGD:151361175 |
NCBI chrNW_004955475:243,666...278,064
Ensembl chrNW_004955475:243,666...278,627
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations:: |
RGD MouseDO |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
exacerbates |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:33014052 |
RGD:150429786 |
NCBI chrNW_004955440:7,048,527...8,475,566
Ensembl chrNW_004955440:7,050,135...8,475,122
|
|
G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004955517:54,699...654,398
Ensembl chrNW_004955517:55,091...655,638
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:27864835 PMID:30377796 |
RGD:150340628 RGD:152998946 |
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Pten |
phosphatase and tensin homolog |
disease_progression |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
mRNA, protein:decreased expression:liver, bile duct epithelium (human) |
RGD |
PMID:26980022 |
RGD:151361125 |
NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762
|
|
G |
S100b |
S100 calcium binding protein B |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004955407:42,972,584...42,980,510
Ensembl chrNW_004955407:42,972,584...42,980,510
|
|
G |
Smad4 |
SMAD family member 4 |
disease_progression |
ISO |
mRNA,protein:decreased expression:intrahepatic bile duct |
RGD |
PMID:16917866 PMID:23981608 |
RGD:18936999 RGD:21066336 |
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
|
|
G |
Tep1 |
telomerase associated protein 1 |
|
ISO |
mRNA:increased expression:hepatocyte,biliary epithelium. |
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chrNW_004955550:1,162,067...1,215,746
Ensembl chrNW_004955550:1,162,186...1,215,723
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Klatskin tumor |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
DNA:deletions |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
onset |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955444:11,154,318...11,414,680
Ensembl chrNW_004955444:11,154,318...11,414,075
|
|